Thoughtworks Holding's low P/S ratio is likely due to poor revenue performance and expectations of this trend continuing. The company's inferior revenue forecasts compared to the industry may contribute to the low P/S ratio, suggesting the share price may not rise significantly soon.
$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks. Here are some top stocks in the sector climbing on drug trial and earnings news: $Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap. $Ligand Pharmaceuticals (LGND.US)$gained 23%...
Thoughtworks Holding's downward trend in ROCE and the continued usage of the same amount of capital signify a potentially mature business showing signs of decline. Unless there's a shift in these metrics, it might be wise to consider investing elsewhere.
Insiders' purchase of shares above current prices signifies optimism for the stock's value and an alignment with shareholder interests. Despite no insider transactions in the last three months, Thoughtworks Holding insiders seem undeterred about the company's future.
Introduction The Digital IT Services group is expected to see a downside risk to its estimates, given weak demand for project-based services and possible delays in bookings ramp. Although snap-back potential to pre-pandemic growth rates is seen at some point next year, there is still caution in the group until stability in estimates is observed. Revision risk is possible, and negative revision trends have be...
Thoughtworks股票討論區
專欄Biotechnology Stocks Climbing on Earnings and Test Results: What to Watch
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
Daily alerts recap 🔥 ALL STARS 🌟 45%+
專欄US Top Gap Ups and Downs on 8/8: LLY, FOX, TWKS, DDOG and More
Gap Ups
1. $諾和諾德(NVO.US)$ - up 13.4%
2. $禮來(LLY.US)$ - up 10.5%
3. $詹姆斯哈迪(JHX.US)$ - up 10.1%
4. $紐約時報(NYT.US)$ - up 3.3%
5. $浦項鋼鐵(PKX.US)$ - up 2.9%
6. $福克斯公司-B(FOX.US)$ - up 2.8%
7. $福克斯公司-A(FOXA.US)$ - up 2.8%
8. $West Pharmaceutical Services(WST.US)$ - up 2.5...
8/9 watchlist ⚡️
$阿克邁(AKAM.US)$$Bruush Oral Care(BRSH.US)$$Extra Space Storage(EXR.US)$$INVO Bioscience(INVO.US)$$Leju Holdings(LEJU.US)$$908 Devices(MASS.US)$$Marqeta(MQ.US)$$佩恩國民博彩(PENN.US)$$Proterra(PTRA.US)$$Salarius Pharmaceuticals(SLRX.US)$$超微電腦(SMCI.US)$$Tango Therapeutics(TNGX.US)$$Thoughtworks(TWKS.US)$$Twilio(TWLO.US)$$永利度假村(WYNN.US)$
專欄Digital IT Services Preview | Not Out of the Woods Yet On Negative Estimate Revision Risk
The Digital IT Services group is expected to see a downside risk to its estimates, given weak demand for project-based services and possible delays in bookings ramp. Although snap-back potential to pre-pandemic growth rates is seen at some point next year, there is still caution in the group until stability in estimates is observed. Revision risk is possible, and negative revision trends have be...
暫無評論